Dustin A Deming (Dustin Deming)

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Radiation Induced

Metastatic Colorectal Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

JCO precision oncology

Current oncology reports

This page only lists publications with an associated author ORCID identifier.

Publications

Sean R O'Neil, Garrett A Weber, Dustin A Deming, Mark E Burkard, Paraic A Kenny, Craig S Richmond, Benjamin M Parsons
Exceptional Response to Crizotinib With Subsequent Response to Cabozantinib in Metastatic, ROS1-GOPC Fusion-Mutated Breast Cancer. JCO precision oncology 7 (2023)
Van Karlyle Morris, Erin B Kennedy, Nancy N Baxter, Al Bowen Benson, Andrea Cercek, May Cho, Kristen K Ciombor, Chiara Cremolini, Anjee Davis, Dustin A Deming, Marwan G Fakih, Sepideh Gholami, Theodore S Hong, Ishmael Jaiyesimi, Kelsey A Klute, Christopher H Lieu, Hanna K Sanoff, John H Strickler, Sarah White, Jason A Willis, Cathy Eng
Treatment of Metastatic Colorectal Cancer: ASCO Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Senthil Damodaran, Fengmin Zhao, Dustin A Deming, Edith P Mitchell, John J Wright, Robert C Gray, Victoria Wang, Lisa Meier McShane, Lawrence V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Jennifer M Suga, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaherty
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (14) (2022)
Sean Kraus, Thomas Kolman, Austin Yeung, Dustin A Deming
Chemokine Receptor Antagonists: Role in Oncology. Current oncology reports 23 (11) (2021)